Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

New substrates have been developed which can be used to raise stem cells for a wide variety of uses.

By taking over the LIMS business, the GUS Group is expanding its offering of solutions both for the process industry as well as for analyzing and controlling institutes and is thus expanding its position as a process expert.

Sysmex America has announced its latest innovation: a way to make quality assurance easier and more risk free than manual quality control processes.

CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.

A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.